Cardiovascular Complication following Covishield Vaccination in Nepal: A Case Report
Nepal started the COVID-19 vaccination on 27 January 2021 with AstraZeneca/Oxford Coronavirus Disease-19 AZD1222 (Covishield) vaccine to control the Coronavirus disease pandemic. The vaccine has a good safety profile, with cardiovascular complications being rare. Herein we report a rare case of car...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nepal Medical Association
2021-08-01
|
Series: | Journal of Nepal Medical Association |
Subjects: | |
Online Access: | https://www.jnma.com.np/jnma/index.php/jnma/article/view/6454 |
id |
doaj-f9397936c97e4142b17ef002f5eb1bd6 |
---|---|
record_format |
Article |
spelling |
doaj-f9397936c97e4142b17ef002f5eb1bd62021-08-14T18:29:13ZengNepal Medical AssociationJournal of Nepal Medical Association0028-27151815-672X2021-08-015924010.31729/jnma.6454Cardiovascular Complication following Covishield Vaccination in Nepal: A Case ReportAngela Basnet0Shiva Kumar Ojha1Suman Kumar Jha2Anjana Paudyal3Manoj Khadka4Manita Khadka5Dhan Bahadur Shrestha6Department of Internal Medicine, Scheer Memorial Adventist Hospital, Banepa, Kavrepalanchok, NepalDepartment of Internal Medicine, Scheer Memorial Adventist Hospital, Banepa, Kavrepalanchok, NepalDepartment of Internal Medicine, Scheer Memorial Adventist Hospital, Banepa, Kavrepalanchok, NepalDepartment of Internal Medicine, Scheer Memorial Adventist Hospital, Banepa, Kavrepalanchok, NepalNepalese Army Institute of Health Sciences, Sanobharyang, Kathmandu, NepalNepalese Army Institute of Health Sciences, Sanobharyang, Kathmandu, NepalDepartment of Internal Medicine, Mount Sinai Hospital, Chicago, USA Nepal started the COVID-19 vaccination on 27 January 2021 with AstraZeneca/Oxford Coronavirus Disease-19 AZD1222 (Covishield) vaccine to control the Coronavirus disease pandemic. The vaccine has a good safety profile, with cardiovascular complications being rare. Herein we report a rare case of cardiovascular complication following Covishield vaccination in a 33 years old female who had dizziness and elevated blood pressure immediately following vaccination and abnormal electrocardiogram showing T wave inversions followed by left bundle branch block. The patient was kept on observation, following which the blood pressure and electrocardiogram changes were normal by seven days. This cardiovascular complication following the vaccination demands further investigation into the adverse event of the vaccine. However, since the benefit of the vaccine outweighs the risk, World Health Organization has recommended the continuity of the vaccine as of now. https://www.jnma.com.np/jnma/index.php/jnma/article/view/6454bundle-branch block; case report; COVID-19 vaccine; Nepal. |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Angela Basnet Shiva Kumar Ojha Suman Kumar Jha Anjana Paudyal Manoj Khadka Manita Khadka Dhan Bahadur Shrestha |
spellingShingle |
Angela Basnet Shiva Kumar Ojha Suman Kumar Jha Anjana Paudyal Manoj Khadka Manita Khadka Dhan Bahadur Shrestha Cardiovascular Complication following Covishield Vaccination in Nepal: A Case Report Journal of Nepal Medical Association bundle-branch block; case report; COVID-19 vaccine; Nepal. |
author_facet |
Angela Basnet Shiva Kumar Ojha Suman Kumar Jha Anjana Paudyal Manoj Khadka Manita Khadka Dhan Bahadur Shrestha |
author_sort |
Angela Basnet |
title |
Cardiovascular Complication following Covishield Vaccination in Nepal: A Case Report |
title_short |
Cardiovascular Complication following Covishield Vaccination in Nepal: A Case Report |
title_full |
Cardiovascular Complication following Covishield Vaccination in Nepal: A Case Report |
title_fullStr |
Cardiovascular Complication following Covishield Vaccination in Nepal: A Case Report |
title_full_unstemmed |
Cardiovascular Complication following Covishield Vaccination in Nepal: A Case Report |
title_sort |
cardiovascular complication following covishield vaccination in nepal: a case report |
publisher |
Nepal Medical Association |
series |
Journal of Nepal Medical Association |
issn |
0028-2715 1815-672X |
publishDate |
2021-08-01 |
description |
Nepal started the COVID-19 vaccination on 27 January 2021 with AstraZeneca/Oxford Coronavirus Disease-19 AZD1222 (Covishield) vaccine to control the Coronavirus disease pandemic. The vaccine has a good safety profile, with cardiovascular complications being rare. Herein we report a rare case of cardiovascular complication following Covishield vaccination in a 33 years old female who had dizziness and elevated blood pressure immediately following vaccination and abnormal electrocardiogram showing T wave inversions followed by left bundle branch block. The patient was kept on observation, following which the blood pressure and electrocardiogram changes were normal by seven days. This cardiovascular complication following the vaccination demands further investigation into the adverse event of the vaccine. However, since the benefit of the vaccine outweighs the risk, World Health Organization has recommended the continuity of the vaccine as of now.
|
topic |
bundle-branch block; case report; COVID-19 vaccine; Nepal. |
url |
https://www.jnma.com.np/jnma/index.php/jnma/article/view/6454 |
work_keys_str_mv |
AT angelabasnet cardiovascularcomplicationfollowingcovishieldvaccinationinnepalacasereport AT shivakumarojha cardiovascularcomplicationfollowingcovishieldvaccinationinnepalacasereport AT sumankumarjha cardiovascularcomplicationfollowingcovishieldvaccinationinnepalacasereport AT anjanapaudyal cardiovascularcomplicationfollowingcovishieldvaccinationinnepalacasereport AT manojkhadka cardiovascularcomplicationfollowingcovishieldvaccinationinnepalacasereport AT manitakhadka cardiovascularcomplicationfollowingcovishieldvaccinationinnepalacasereport AT dhanbahadurshrestha cardiovascularcomplicationfollowingcovishieldvaccinationinnepalacasereport |
_version_ |
1721207485599055872 |